BMY trims earnings outlook despite revenue beat and upbeat drug sales, sending shares to a 52-week low before a rebound. We ...

A new café opening in the Downtown Grand Rapids Market will offer everything from a cheese counter and wine bar to coffee and ...

The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma ...

Investing in clinical-stage biotechnology always carries significant risks, and aTyr is no exception. The company reported a ...

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...

Type II cryoglobulinemic vasculitis in patients with Sjögren disease is associated with nearly a sevenfold increased risk for lymphoma and death in a study.

PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

After beating AstraZeneca’s Calquence in quarterly revenue for the first time at the end of 2024, BeOne Medicines’ Brukinsa ...

Business advice guru Squibb, for whom Hong Kong played a special part is his story, talks about helping people gain financial ...

Contineum Therapeutics has pumped the brakes on two projects, freeing up resources to go full speed ahead in its pursuit of Bristol Myers Squibb in idiopathic pulmonary fibrosis.

Aubrey Plaza’s call sheet is about to get a lot longer, as she’s come on to produce and star in “The Heidi Fleiss Story.” ...

US FDA accepts for priority review Bristol Myers Squibb’s sBLA for Breyanzi to treat adult patients with relapsed or refractory MZL: Princeton, New Jersey Wednesday, August 6, 2 ...